Against this backdrop, we set out to reassess the biologic landscape of candidate susceptibility genes in RA by mapping cis‐ and trans‐eQTLs at 101 established RA risk loci in circulating CD4+ and B lymphocyte subsets sampled from a cohort of untreated patients with early arthritis. This evidence concerns the gene CD4 and arthritic joint disease.